Sugi Predict

Sugi Predict / Compounds / SCHEMBL10162871

SCHEMBL10162871

SCHEMBL10162871

Cn1c(=O)oc2ccc(CNC(=O)c3cc(C(=O)NCc4ccccc4OC(C)(F)F)n4nccc4n3)cc21

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MAPK1 P28482 3/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LMNA P02545 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ TSHR P16473 2/20 0.38
▸ KCNN3 Q9UGI6 1/20 0.37
▸ TP53 P04637 5/20 0.36
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ ATM Q13315 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ METTL3 Q86U44 1/20 0.35
▸ METTL14 Q9HCE5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8225358 0.95 KCNN3 (0.42) ALDH1A1MAPTMAPK1ALOX15L3MBTL1
SCHEMBL14449909 0.89 LIPG (0.41) ALDH1A1MAPTMAPK1ALOX15L3MBTL1
SCHEMBL10162869 0.89 ROCK2 (0.41) MAPK1LMNAKCNN3TP53ATM
SCHEMBL10162868 0.89 KCNN3 (0.37) ALDH1A1MAPTMAPK1L3MBTL1LMNA
SCHEMBL10163500 0.89 ADAMTS4 (0.40) ALDH1A1MAPTMAPK1ALOX15L3MBTL1
SCHEMBL10162861 0.88 ALDH1A1 (0.40) ALDH1A1MAPTMAPK1ALOX15L3MBTL1
SCHEMBL10162851 0.87 MAPT (0.47) ALDH1A1MAPTMAPK1ALOX15L3MBTL1
SCHEMBL10162873 0.87 TP53 (0.44) ALDH1A1MAPTALOX15L3MBTL1LMNA
SCHEMBL13161664 0.85 METTL3 (0.40) ALDH1A1MAPTLMNAKDM4EHPGD
SCHEMBL10163587 0.85 MMP13 (0.37) ALDH1A1MAPTALOX15L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835441-B2 Heterobicyclic metalloprotease inhibitors AMGEN INC. (US) 2014-09-16 — — US disclosed
US-20120015920-A1 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2012-01-19 — — US disclosed
US-7795245-B2 Heterobicyclic metalloprotease inhibitors Atlantos Pharmaceuticals Holding, Inc. (US) 2010-09-14 — — US disclosed
US-20090312312-A1 Heterobicyclic Metalloprotease Inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2009-12-17 — — US disclosed
US-20090137547-A1 Heterobicyclic metalloprotease inhibitors ALANTOS PHARMACEUTICALS HOLDING, INC. 2009-05-28 — — US disclosed
US-20070155738-A1 Heterobicyclic metalloprotease inhibitors ALANTOS PHARMACEUTICALS, INC. 2007-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312312-A1 Heterobicyclic Metalloprotease Inhibitors MMP13, TIMP3, MMP3 ALDH1A1 1806/4885MAPT 3533/4885MAPK1 2860/4885
US-20120015920-A1 HETEROBICYCLIC METALLOPROTEASE INHIBITORS MMP13, TIMP3, MMP3 ALDH1A1 1806/4885MAPT 3533/4885MAPK1 2860/4885
US-20090137547-A1 Heterobicyclic metalloprotease inhibitors MMP13, TIMP3, MMP3 ALDH1A1 1806/4885MAPT 3533/4885MAPK1 2860/4885
US-20070155738-A1 Heterobicyclic metalloprotease inhibitors MMP13, TIMP3, MMP3 ALDH1A1 1806/4885MAPT 3533/4885MAPK1 2860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.